Show simple item record

Semiparametric Inference for Surrogate Endpoints with Bivariate Censored Data

dc.contributor.authorGhosh, Debashisen_US
dc.date.accessioned2010-04-01T15:06:47Z
dc.date.available2010-04-01T15:06:47Z
dc.date.issued2008-03en_US
dc.identifier.citationGhosh, Debashis (2008). "Semiparametric Inference for Surrogate Endpoints with Bivariate Censored Data." Biometrics 64(1): 149-156. <http://hdl.handle.net/2027.42/65578>en_US
dc.identifier.issn0006-341Xen_US
dc.identifier.issn1541-0420en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/65578
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=17651457&dopt=citationen_US
dc.description.abstractConsiderable attention has been recently paid to the use of surrogate endpoints in clinical research. We deal with the situation where the two endpoints are both right censored. While proportional hazards analyses are typically used for this setting, their use leads to several complications. In this article, we propose the use of the accelerated failure time model for analysis of surrogate endpoints. Based on the model, we then describe estimation and inference procedures for several measures of surrogacy. A complication is that potentially both the independent and dependent variable are subject to censoring. We adapt the Theil–Sen estimator to this problem, develop the associated asymptotic results, and propose a novel resampling-based technique for calculating the variances of the proposed estimators. The finite-sample properties of the estimation methodology are assessed using simulation studies, and the proposed procedures are applied to data from an acute myelogenous leukemia clinical trial.en_US
dc.format.extent190893 bytes
dc.format.extent3110 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Incen_US
dc.rights2007 International Biometric Societyen_US
dc.subject.otherClayton–Oakes Modelen_US
dc.subject.otherCopulaen_US
dc.subject.otherLinear Regressionen_US
dc.subject.otherPrentice Criterionen_US
dc.subject.otherStochastic Perturbationen_US
dc.subject.otherU -Statisticen_US
dc.titleSemiparametric Inference for Surrogate Endpoints with Bivariate Censored Dataen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMathematicsen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Biostatistics, University of Michigan, 1420 Washington Heights, Ann Arbor, Michigan 48105, U.S.A. email: ghoshd@umich.eduen_US
dc.identifier.pmid17651457en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/65578/1/j.1541-0420.2007.00834.x.pdf
dc.identifier.doi10.1111/j.1541-0420.2007.00834.xen_US
dc.identifier.sourceBiometricsen_US
dc.identifier.citedreferenceAkritas, M. G., Murphy, S. A., and LaValley, M. P. ( 1995 ). The Theil–Sen estimator with doubly censored data and applications to astronomy. Journal of the American Statistical Association 90, 170 – 177.en_US
dc.identifier.citedreferenceBegg, C. B. and Leung, D. H. Y. ( 2000 ). On the use of surrogate endpoints in randomized trials (with discussion). Journal of the Royal Statistical Society, Series A 163, 15 – 28.en_US
dc.identifier.citedreferenceBerger, V. W. ( 2004 ). Does the Prentice criterion validate surrogate endpoints? Statistics in Medicine 23, 1571 – 1578.en_US
dc.identifier.citedreferenceBerman, E., Heller, G., Santorsa, J., McKenzie, S., Gee, T., Kempin, S., Gulati, S., Andreeff, M., Kolitz, J., and Gabrilove, J. ( 1991 ). Results of a randomized trial comparing idarubicin and cytosine arabinoside with daunorubicin and cytosine arabinoside in adult patients with newly diagnosed acute myelogenous leukemia. Blood 77, 1666 – 1674.en_US
dc.identifier.citedreferenceBiomarkers Working Group. ( 2001 ). Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework. Clinical Pharmacology and Therapeutics 69, 89 – 95.en_US
dc.identifier.citedreferenceBurzykowski, T., Molenberghs, G., Buyse, M., Geys, H., and Renard, D. ( 2001 ). Validation of surrogate endpoints in multiple randomized clinical trials with failure-time endpoints. Applied Statistics 50, 405 – 422.en_US
dc.identifier.citedreferenceBurzykowski, T., Molenberghs, G., and Buyse, M. ( 2005 ). The Evaluation of Surrogate Endpoints. New York : Springer-Verlag.en_US
dc.identifier.citedreferenceBuyse, M. and Molenberghs, G. ( 1998 ). Criteria for the validation of surrogate endpoints in randomized experiments. Biometrics 54, 1014 – 1029.en_US
dc.identifier.citedreferenceClayton, D. G. ( 1978 ). A model for association in bivariate life tables and its application in epidemiological studies of familial tendency in chronic disease incidence. Biometrika 65, 141 – 151.en_US
dc.identifier.citedreferenceCox, D. R. ( 1972 ). Regression models and life tables (with discussion). Journal of the Royal Statistical Society, Series B 34, 187 – 220.en_US
dc.identifier.citedreferenceCox, D. R. and Oakes, D. ( 1984 ). Analysis of Survival Data. London : Chapman and Hall.en_US
dc.identifier.citedreferenceEfron, B. ( 1981 ). Censored data and the bootstrap. Journal of the American Statistical Association 76, 312 – 319.en_US
dc.identifier.citedreferenceEfron, B. and Tibshirani, R. ( 1986 ). Bootstrap method for standard errors, confidence intervals and other measures of statistical accuracy. Statistical Science 1, 54 – 77.en_US
dc.identifier.citedreferenceFine, J. P. and Jiang, H. ( 2000 ). On association in a copula with time transformations. Biometrika 87, 559 – 571.en_US
dc.identifier.citedreferenceFine, J. P., Jiang, H., and Chappell, R. ( 2001 ). On semi-competing risks data. Biometrika 88, 907 – 919.en_US
dc.identifier.citedreferenceFreedman, L. S., Graubard, B. I., and Schatzkin, A. ( 1992 ). Statistical validation of intermediate endpoints for chronic disease. Statistics in Medicine 11, 167 – 178.en_US
dc.identifier.citedreferenceHaferlach, T., Kern, W., Schnittger, S., and Schoch, C. ( 2005 ). Modern diagnostics in acute leukemias. Critical Reviews in Oncology and Hematology 56, 223 – 234.en_US
dc.identifier.citedreferenceJin, Z., Lin, D. Y., Wei, L. J., and Ying, Z. ( 2003 ). Rank-based inference for the accelerated failure time model. Biometrika 90, 341 – 353.en_US
dc.identifier.citedreferenceLin, D. Y., Fleming, T. R., and DeGruttola, V. ( 1997 ). Estimating the proportion of treatment effect explained by a surrogate marker. Statistics in Medicine 16, 1515 – 1527.en_US
dc.identifier.citedreferenceMolenberghs, G., Buyse, M., Geys, H., Renard, D., Burzykowski, T., and Alonso, A. ( 2002 ). Statistical challenges in the evaluation of surrogate endpoints in randomized trials. Controlled Clinical Trials 23, 607 – 625.en_US
dc.identifier.citedreferenceOakes, D. ( 1986 ). Semiparametric inference in a model for association in bivariate survival data. Biometrika 73, 353 – 361.en_US
dc.identifier.citedreferencePetrylak, D. P., Ankerst, D. P., Jiang, C. S., et al. ( 2006 ). Evaluation of prostate-specific antigen declines for surrogacy in patients treated on SWOG 99-16. Journal of the National Cancer Institute 98, 516 – 521.en_US
dc.identifier.citedreferencePrentice, R. L. ( 1989 ). Surrogate endpoints in clinical trials: Definition and operational criteria. Statistics in Medicine 8, 431 – 440.en_US
dc.identifier.citedreferenceSen, P. K. ( 1968 ). Estimates of the regression coefficient based on Kendall's tau. Journal of the American Statistical Association 63, 1379 – 1389.en_US
dc.identifier.citedreferenceShih, J. H. and Louis, T. A. ( 1995 ). Inferences on the association parameter in copula models for bivariate survival data. Biometrics 51, 1384 – 1399.en_US
dc.identifier.citedreferenceTheil, H. ( 1950 ). A rank invariant method of linear and polynomial regression analysis. Koninklijke Nederlandse Akademie var Wetenschappen Proceedings 53, 386 – 392.en_US
dc.identifier.citedreferenceTsiatis, A. A., DeGruttola, V., and Wulfsohn, M. S. ( 1995 ). Modeling the relationship of survival to longitudinal data measured with error: Applications to survival and CD4 counts in patients with AIDS. Journal of the American Statistical Association 90, 27 – 37.en_US
dc.identifier.citedreferenceVan der Vaart, A. ( 2000 ). Asymptotic Statistics. Cambridge : Cambridge University Press.en_US
dc.identifier.citedreferenceWang, Y. and Taylor, J. M. ( 2002 ). A measure of the proportion of treatment effect explained by a surrogate marker. Biometrics 58, 803 – 812.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.